Form 4 Edwards Lifesciences Corp For: 13 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Edwards Lifesciences Corp (EW)
Edwards Lifesciences Corp stock price live, this page displays NYSE EW stock exchange data. View the EW premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Edwards Lifesciences Corp real time stock price chart below.
What Is the Edwards Lifesciences Corp Stock Price Today?
The Edwards Lifesciences Corp stock price today is 91.79.
What Is the Stock Symbol for Edwards Lifesciences Corp?
The stock symbol for Edwards Lifesciences Corp is "EW."
What Stock Exchange Does Edwards Lifesciences Corp Trade On?
Edwards Lifesciences Corp is listed and trades on the NYSE stock exchange.
Is Edwards Lifesciences Corp a Good Stock to Buy?
Determining whether Edwards Lifesciences Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EW quote. (ISIN: US28176E1082)
What Is the Edwards Lifesciences Corp Stock Price Today?
The Edwards Lifesciences Corp stock price today is 91.79.
What Is the Stock Symbol for Edwards Lifesciences Corp?
The stock symbol for Edwards Lifesciences Corp is "EW."
What Stock Exchange Does Edwards Lifesciences Corp Trade On?
Edwards Lifesciences Corp is listed and trades on the NYSE stock exchange.
Is Edwards Lifesciences Corp a Good Stock to Buy?
Determining whether Edwards Lifesciences Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EW quote. (ISIN: US28176E1082)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
91.50
93.09
52 wk Range
72.30
96.29
Earnings results expected in 9 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
91.5093.09
52 wk Range
72.3096.29
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EW Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
98.31
Upside
+7.10%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Form 4 Edwards Lifesciences Corp For: 7 July
- Investing.com
- Form 4 Edwards Lifesciences Corp For: 13 July
- Investing.com
- Form 4 Edwards Lifesciences Corp For: 10 July
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Analyst Ratings
21 Buy
8 Hold
0 Sell
Ratings:
29 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 98.31
(+7.10% Upside)
Edwards Lifesciences Corp SWOT Analysis
Market Share Gains | Edwards Lifesciences positioned to capture 15-20% of competitor's TAVR market share following Medtronic's data challenges and strategic shifts |
Analyst Outlook | Price targets range from $92 to $104, with consensus Overweight ratings reflecting confidence in competitive positioning and clinical pipeline strength |
Strategic Pipeline | Five-year growth plan emphasizes innovation across TAVR, transcatheter mitral and tricuspid therapies, supported by solid Phase 3 clinical trial results |
Valuation Dynamics | Premium valuation reflects market leadership in transcatheter aortic valve technology, though international price sensitivity may temper geographic expansion |
Edwards Lifesciences Corp Earnings Call Summary for Q1/2026
- Q1 2026 revenue hit $1.65B (up 12.7% YoY), beating estimates of $1.6B; adjusted EPS of $0.78 exceeded forecast of $0.73 by 6.85%.
- Strong performance driven by TAVR and TMTT product lines, with adjusted gross profit margin at 78.2% and cash reserves of $2.4B.
- Full-year 2026 sales growth guidance raised to 9%-11% from 8%-10%; adjusted EPS guidance increased to $2.95-$3.05 range.
- CEO Mussallem cited strategic investments and innovation as key drivers; stock rose 0.16% after-hours to $81.66 despite 2.15% regular session decline.
- Key risks include currency fluctuations, heightened structural heart market competition, supply chain disruptions, and regulatory changes in major markets.
Last Updated: 04/24/2026, 06:26 AM
Read Full TranscriptEarnings
Latest Release
Apr 23, 2026
EPS / Forecast
0.78 / 0.73
Revenue / Forecast
1.65B / 1.6B
Compare EW to Peers and Sector
Metrics to compare | EW | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEWPeersSector | |
|---|---|---|---|---|
P/E Ratio | 49.1x | 28.7x | −0.4x | |
PEG Ratio | −0.67 | 0.16 | 0.00 | |
Price/Book | 5.1x | 2.6x | 2.6x | |
Price / LTM Sales | 8.4x | 2.5x | 3.0x | |
Upside (Analyst Target) | 8.9% | 49.5% | 52.8% | |
Fair Value Upside | Unlock | 18.4% | 9.7% | Unlock |
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Edwards Lifesciences (EW) Stock Price Today?
The Edwards Lifesciences stock price today is 91.79 USD.
What Stock Exchange Does Edwards Lifesciences Trade On?
Edwards Lifesciences is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Edwards Lifesciences?
The stock symbol for Edwards Lifesciences is "EW."
What Is the Edwards Lifesciences Market Cap?
As of today, Edwards Lifesciences market cap is 52.85B USD.
What Is Edwards Lifesciences's Earnings Per Share (TTM)?
The Edwards Lifesciences EPS (TTM) is 1.85.
When Is the Next Edwards Lifesciences Earnings Date?
Edwards Lifesciences will release its next earnings report on Jul 23, 2026.
From a Technical Analysis Perspective, Is EW a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Edwards Lifesciences Stock Split?
Edwards Lifesciences has split 3 times.
How Many Employees Does Edwards Lifesciences Have?
Edwards Lifesciences has 16000 employees.
What is the current trading status of Edwards Lifesciences (EW)?
As of Jul 14, 2026, Edwards Lifesciences (EW) is trading at a price of 91.79 USD, with a previous close of 91.79 USD. The stock has fluctuated within a day range of 91.50 USD to 93.09 USD, while its 52-week range spans from 72.30 USD to 96.29 USD.
What Is Edwards Lifesciences (EW) Price Target According to Analysts?
The average 12-month price target for Edwards Lifesciences is 98.31 USD, with a high estimate of 110 USD and a low estimate of 84 USD. 21 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +7.10% Upside potential.
What Is the EW Premarket Price?
EW's last pre-market stock price is 92.85 USD. The pre-market share volume is 210.00, and the stock has decreased by 0.64, or 0.69%.
What Is the EW After Hours Price?
EW's last after hours stock price is 90.75 USD, the stock has decreased by -1.04, or -1.13%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.